Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW 5,530.00
+160.00 (2.98%)
Nov 2, 2026, 3:30 PM KST
Hyundai Bioscience Market Cap
Hyundai Bioscience has a market cap or net worth of 533.66 billion as of October 30, 2026. It is the 16,016th most valuable company in the world and the 429th biggest in South Korea. Its market cap has increased by 6.45% in one year.
Market Cap
533.66B
Enterprise Value
513.88B
Revenue
3.32B
Global Rank
Country Rank
#429 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 533.66B, an increase of 1,023.64%. That is a compound annual growth rate of 10.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 533.66B | 11.92% |
| Dec 30, 2025 | 476.83B | -15.13% |
| Dec 30, 2024 | 561.85B | -45.92% |
| Dec 28, 2023 | 1.04T | -4.44% |
| Dec 29, 2022 | 1.09T | 11.39% |
| Dec 30, 2021 | 976.10B | -6.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Komipharm International | 651.95B |
| Chabiotech | 624.39B |
| Proteina | 599.21B |
| Pharmicell | 564.04B |
| Onconic Therapeutics | 549.89B |
| GI Innovation | 434.19B |
| GC Corp. | 415.33B |
| Medy-Tox | 412.68B |